Non-invasive Risk Stratification of CR AMN/SSP

NCT02476682 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 205

Last updated 2025-03-27

No results posted yet for this study

Summary

The purpose of this study is to determine the clinical utility of stool and blood methylation tests for detection of advanced mucosal neoplasia (AMN) and sessile serrated polyps (SSP).

Conditions

  • Adenomatous Polyps

Interventions

OTHER

blood or stool samples will be collected

blood or stool samples will be collected

Sponsors & Collaborators

  • Professor Michael Bourke

    lead OTHER

Principal Investigators

  • Michael J Bourke, MBBS FRACP · Westmead Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-11
Primary Completion
2020-07-31
Completion
2021-07-31

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02476682 on ClinicalTrials.gov